Growth Metrics

Envoy Medical (COCH) Other financing activities (2021 - 2026)

Envoy Medical recorded quarterly Other financing activities of $208000.0 in Q1 2026, up 136.24% quarter-over-quarter from -$574000.0 in Q4 2025, and down 10.73% year-over-year from $233000.0 in Q1 2025.

Envoy Medical's Other financing activities history runs 4 years deep, the most recent figure standing at $208000.0 for Q1 2026.

  • In Q1 2026, Other financing activities fell 10.73% year-over-year to $208000.0; the TTM figure through Mar 2026 stood at $37000.0 (down 95.85% YoY), while the FY2025 annual figure was $62000.0, down 93.23% from the prior year.
  • Other financing activities came in at $208000.0 for Q1 2026 at Envoy Medical, up from -$574000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $262000.0 in Q2 2024 to a low of -$574000.0 in Q4 2025.
  • A 3-year average of $131777.8 and a median of $213000.0 in 2024 frame the typical range for Other financing activities.
  • On a YoY basis, Other financing activities climbed as much as 9.24% in 2025 and fell as far as 369.48% in 2025.
  • Envoy Medical's Other financing activities stood at $213000.0 in 2024, then slumped by 369.48% to -$574000.0 in 2025, then surged by 136.24% to $208000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered $208000.0, -$574000.0, and $167000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Envoy Medical 48.11 Mn 22.86 Mn -274,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 208,000.00
Mar 31, 2026 208,000.00
Dec 31, 2025 -574,000.00
Dec 31, 2025 -574,000.00
Sep 30, 2025 167,000.00
Sep 30, 2025 167,000.00
Jun 30, 2025 236,000.00
Jun 30, 2025 236,000.00
Mar 31, 2025 233,000.00
Mar 31, 2025 233,000.00
Dec 31, 2024 213,000.00
Dec 31, 2024 213,000.00
Sep 30, 2024 184,000.00
Sep 30, 2024 184,000.00
Jun 30, 2024 262,000.00
Jun 30, 2024 262,000.00
Mar 31, 2024 257,000.00
Mar 31, 2024 257,000.00
Dec 31, 2021 -3,000.00
Dec 31, 2021 -3,000.00
Sep 30, 2021 8.35 Mn
Sep 30, 2021 8.35 Mn
Jun 30, 2021 161,238.00
Jun 30, 2021 161,238.00
Mar 31, 2021 621,574.00
Mar 31, 2021 621,574.00